Titlebook: Angiotensin Receptors; Juan M. Saavedra,Pieter B. M. W. M. Timmermans Book 1994 Springer Science+Business Media New York 1994 Angiotensin

Clinical-Trial

书目名称Angiotensin Receptors影响因子(影响力)




书目名称Angiotensin Receptors影响因子(影响力)学科排名




书目名称Angiotensin Receptors网络公开度




书目名称Angiotensin Receptors网络公开度学科排名




书目名称Angiotensin Receptors被引频次




书目名称Angiotensin Receptors被引频次学科排名




书目名称Angiotensin Receptors年度引用




书目名称Angiotensin Receptors年度引用学科排名




书目名称Angiotensin Receptors读者反馈




书目名称Angiotensin Receptors读者反馈学科排名

abnegate

责问

The European Union in International Affairsrd the design and synthesis of AT.-specific ligands. However, as losartan (DuP 753). and numerous other AT.-selective antagonists. progress through the clinical departments. of pharmaceutical companies, one is left to consider the clinical consequence of AT. receptor activation. Although at present

BACLE

EU Policies towards Latin America,ignaling properties. The pharmacology of AT. receptors is the focus of this chapter; AT. receptors. as well as cytosolic and nuclear angiotensin-binding proteins. have been described elsewhere in this book and are not covered here.

唤起

Interdisciplinary Studies in Human Rightssin system during conditions of infarction-induced cardiac decompensation engenders increases in circulating levels of angiotensin II (ANG II), a major pressor agent.. To reduce the work load on this already compromised ventricle and possibly prevent the associated detrimental changes in chamber geo

Compatriot

Interdisciplinary Studies in Human Rightsgiotensin receptor. This differentiation is particularly germane in congestive heart failure because this is a clinical syndrome in which the renin—angiotensin system is activated. and converting enzyme inhibition is now conventional therapy for this disease.

绊住

Defining Angiotensin Receptor Subtypes,ibited one population of ANG II binding sites, whereas PD 123177 selectively inhibited the other losartan-resistant site.. A similar observation was independently established by using losartan and a novel peptide ligand, CGP 42112A, which also showed selectivity for the losartan-resistant site.. Sub

fibula

Medicinal Chemistry of Angiotensin II Antagonists,e ANG II receptor antagonists would lack the disadvantages associated with peptide ANG II receptor antagonists and would also be potentially more selective than ACE inhibitors for blocking the RAS was an attractive but elusive strategy until 1982 when Furukawa and co-workers at Takeda Chemical Indus

一骂死割除

organism

Pharmacology of AT2 Receptors,ignaling properties. The pharmacology of AT. receptors is the focus of this chapter; AT. receptors. as well as cytosolic and nuclear angiotensin-binding proteins. have been described elsewhere in this book and are not covered here.